Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunological Tolerance After Frequent Rabies Booster Vaccinations
NCT03729102Unknown
- Sponsor
- Queen Saovabha Memorial Institute
- Start
- Jun 2020
- Primary completion
- Dec 2023
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Open-label trial of Rabies vaccine in rabies (2 arms), sponsored by Queen Saovabha Memorial Institute. Primary endpoints: Rabies specific regulatory T cells at 1 month, Rabies specific regulatory B cells at 1 month and 1 more. Status: unknown.
02
Drugs
Rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on NCT03729102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03729102.